Abstract | BACKGROUND: AIM: Aim of our study is to analyze glucose control in acromegalic patients with diabetes, evaluating the relation with treatments for GH excess and for diabetes. METHODS: Seventy patients with acromegaly and diabetes were studied. Duration and treatments of acromegaly and diabetes were recorded, together with clinical and metabolic parameters. RESULTS: Most patients (92.8%) were treated with somatostatin analogs (SSA), either alone or in combination with dopamine-agonists (20%) or pegvisomant (15.7%); 7.1% of patients had been treated by surgery alone. Metformin (65.7%), alone or in combination with other hypoglycemic drugs, was the most frequent treatment for diabetes, followed by insulin (21.5%). Only 15.7% were treated with diet alone. The whole cohort showed a very good control of diabetes and acromegaly. Median glycated hemoglobin was 6.4% (5.9-7). IGF-I was within normal range for age in most patients. No relation was observed between duration of acromegaly or diabetes and metabolic control. SSA had a negative effect on insulin secretion, but these effects did not influence glucose control. Finally, we observed a low prevalence of nephropathy (6%) and retinopathy (20%). CONCLUSIONS: Our study shows that a good control of hyperglycemia can be obtained with success in the majority of acromegalic patients with diabetes, independently of the type of treatment for GH excess.
|
Authors | V M Cambuli, M Galdiero, M Mastinu, F Pigliaru, R S Auriemma, A Ciresi, R Pivonello, M Amato, C Giordano, S Mariotti, A Colao, M G Baroni |
Journal | Journal of endocrinological investigation
(J Endocrinol Invest)
Vol. 35
Issue 2
Pg. 154-9
(Feb 2012)
ISSN: 1720-8386 [Electronic] Italy |
PMID | 21532330
(Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Blood Glucose
- Dopamine Agonists
- Glycated Hemoglobin A
- hemoglobin A1c protein, human
- Human Growth Hormone
- Somatostatin
|
Topics |
- Acromegaly
(blood, complications, metabolism, therapy)
- Aged
- Blood Glucose
(drug effects, metabolism)
- Cohort Studies
- Diabetes Complications
(blood, metabolism, therapy)
- Diabetes Mellitus
(blood, metabolism, therapy)
- Dopamine Agonists
(therapeutic use)
- Endocrine Surgical Procedures
- Glycated Hemoglobin
(metabolism)
- Human Growth Hormone
(blood)
- Humans
- Hyperglycemia
(blood, metabolism, therapy)
- Middle Aged
- Somatostatin
(analogs & derivatives, therapeutic use)
|